Semaglutide has changed the conversation around medical weight loss. It is not a diet pill or a stimulant. It is a medication that works with the biology of weight regulation, addressing the hormonal signals that drive hunger, not just willpower. If you have heard the name and wondered whether it might be an option for you, here is what you need to know.
What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist, a class of medication that mimics glucagon-like peptide-1 (GLP-1), a hormone your gut naturally produces after you eat to signal fullness and regulate blood sugar. It was originally developed to manage blood sugar in adults with type 2 diabetes and is widely recognized under the brand name Ozempic.
In 2021, the FDA approved a higher-dose formulation of semaglutide under the brand name Wegovy specifically for chronic weight management in adults with obesity or overweight. This was a significant milestone: it was the first approval of a new weight-loss medication in nearly a decade, and clinical trial data showed results that far exceeded previous options. At Florida Aesthetics and Wellness, semaglutide is offered as a weekly subcutaneous injection as part of a supervised medical weight loss program.
How Does Semaglutide Work?
To understand why semaglutide is effective, it helps to understand what GLP-1 normally does. When you eat, your intestines release GLP-1 into the bloodstream. This hormone signals your brain that you are full, slows the movement of food through your stomach (a process called gastric emptying), and reduces appetite between meals.
In many people who struggle with weight, these signals are blunted or dysregulated. The hunger drive wins more often than it should, and the body resists weight loss through a variety of compensatory mechanisms.
Semaglutide works by binding to GLP-1 receptors throughout the body with a sustained effect that lasts approximately one week per dose. The result:
- The brain receives more consistent fullness signals
- Gastric emptying slows, so you feel satisfied longer after smaller meals
- Appetite and food cravings decrease over time
- The hunger-reward cycle that drives overeating is recalibrated at a neurological level
This is not short-term appetite suppression. Research suggests semaglutide actually retrains the hunger signals that make sustained weight loss so difficult for most people.
What Do the Clinical Results Show?
The STEP clinical trials (Semaglutide Treatment Effect in People with Obesity) are the primary evidence base for semaglutide as a weight-loss medication. In the landmark STEP 1 trial, participants receiving semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of 14.9% of their body weight over 68 weeks. That is compared to approximately 2.4% in the placebo group.
Some participants lost considerably more. Roughly one in three participants lost 20% or more of their body weight. These are outcomes that historically required bariatric surgery to achieve. For a real-world example of what that kind of progress can look like, read about one patient's journey from 184 to 137 pounds with semaglutide and tirzepatide.
Who Is a Candidate for Semaglutide?
FDA labeling for weight-management semaglutide (Wegovy) covers adults who meet one of the following criteria:
- A BMI of 30 or higher (classified as obese)
- A BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
Semaglutide is not appropriate for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). A thorough medical evaluation at Florida Aesthetics and Wellness will assess your full health history to determine whether semaglutide or an alternative weight loss approach is the right fit.
Important Note on Candidacy
Semaglutide is a prescription medication and requires a medical evaluation before it can be prescribed. At Florida Aesthetics and Wellness, every patient starts with a comprehensive consultation that reviews health history, current medications, and weight-loss goals. We do not prescribe semaglutide without this evaluation.
What to Expect at Florida Aesthetics and Wellness
Your first step is a medical evaluation with our team at Florida Aesthetics and Wellness. If semaglutide is appropriate for you, we typically begin at a low starting dose and titrate upward gradually over weeks to months. This titration schedule exists for a reason: starting low and increasing slowly significantly reduces the likelihood of gastrointestinal side effects.
Throughout your program, you will have regular check-ins with your provider to monitor progress, assess tolerability, and adjust your plan as needed. We also incorporate nutrition guidance and body composition analysis to track changes in fat mass versus lean muscle, giving you a clearer picture of what is actually shifting beyond the scale. Learn why body composition analysis matters more than weight alone.
Our goal is not to hand you a prescription and send you home. Semaglutide works best as part of a structured, supervised program that addresses the full picture of your health.
What Are the Side Effects?
The most commonly reported side effect is nausea, particularly during the early weeks as your body adjusts to the medication and as the dose increases. For most patients, nausea is manageable and improves significantly once they reach a stable therapeutic dose.
Other reported side effects include constipation and fatigue, especially early in treatment. Most patients tolerate semaglutide well at their target dose, and many report that side effects fade substantially after the first few weeks at each new dose level.
Eating smaller, lower-fat meals and staying well hydrated can help reduce GI discomfort during titration. Your provider will give you specific guidance based on your experience.
Semaglutide vs. Tirzepatide: Is There a Difference?
Since semaglutide first gained widespread attention, another medication has entered the conversation: tirzepatide, available under the brand names Mounjaro and Zepbound. Where semaglutide targets only the GLP-1 receptor, tirzepatide is a dual GLP-1/GIP agonist, meaning it activates two separate gut-hormone pathways. GIP (glucose-dependent insulinotropic polypeptide) is a second fullness-and-insulin hormone that works alongside GLP-1, amplifying the effect on appetite regulation and glucose metabolism.
Clinical trials for tirzepatide have shown even greater average weight loss in some head-to-head analyses. This does not mean tirzepatide is the right choice for every patient, but it is now an option at Florida Aesthetics and Wellness for those who may benefit from it. Learn more about tirzepatide at Florida Aesthetics and Wellness.
The best medication is the one that is medically appropriate for you specifically, and that determination happens through a proper evaluation with a qualified provider, not by comparing before-and-after photos online.
Taking the Next Step
If you have been struggling to lose weight despite genuine effort, or if your weight is affecting your health in ways your current approach has not addressed, semaglutide at Florida Aesthetics and Wellness may be worth discussing. Our board-certified anti-aging specialists provide medically supervised care in a private, supportive environment at our Brandon, FL office.
Start with a complimentary consultation. We will review your health history, talk through your goals, and help you understand all of your options across our full medical weight loss program.
Frequently Asked Questions
What is semaglutide and how does it work for weight loss?
Semaglutide is a GLP-1 receptor agonist, a medication that mimics glucagon-like peptide-1, a hormone your gut naturally produces after eating. It works by sending sustained fullness signals to the brain, slowing gastric emptying so you feel satisfied longer after smaller meals, and reducing appetite and food cravings over time. It is given as a weekly subcutaneous injection as part of a medically supervised program.
Who qualifies for semaglutide for weight loss?
FDA labeling for weight-management semaglutide (Wegovy) covers adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol. Semaglutide is not appropriate for patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). A medical evaluation is required before it can be prescribed.
What side effects are most common with semaglutide?
The most commonly reported side effect is nausea, particularly during the early weeks as the body adjusts and as the dose increases. Other reported side effects include constipation and fatigue, especially early in treatment. For most patients these effects improve significantly once a stable therapeutic dose is reached. Eating smaller, lower-fat meals and staying well hydrated can help reduce gastrointestinal discomfort during the titration period.
What is the difference between semaglutide and tirzepatide?
Semaglutide targets only the GLP-1 receptor, while tirzepatide is a dual GLP-1/GIP agonist that activates two separate hormone pathways involved in appetite regulation and glucose metabolism. GIP stands for glucose-dependent insulinotropic polypeptide, a second gut hormone that works alongside GLP-1. Clinical trials for tirzepatide have shown greater average weight loss in some analyses, but the right medication depends on each patient's individual medical profile and goals.
How long does it take to see results with semaglutide?
Results vary by individual. In the STEP 1 clinical trial, participants receiving semaglutide 2.4 mg weekly alongside lifestyle changes lost an average of 14.9% of their body weight over 68 weeks. The dose is typically started low and increased gradually over weeks to months, so meaningful weight loss is generally observed over several months of consistent use. Individual results depend on starting weight, diet, activity level, and medical history.
Is semaglutide available at Florida Aesthetics and Wellness in Brandon, FL?
Yes. Florida Aesthetics and Wellness in Brandon, FL offers semaglutide as part of a supervised medical weight loss program. Every patient begins with a comprehensive medical evaluation to review health history, current medications, and weight-loss goals before any prescription is considered. Tirzepatide is also available for patients who may be better suited to that option.
This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified medical provider to determine whether semaglutide or any other weight-loss medication is appropriate for your individual situation.